BioNTech SE is 12.0x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($22.90 B vs $1.90 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADMA | BNTX |
|---|---|---|
| Market cap | $1.90 B | $22.90 B |
| US-listed rank | #2141 | #572 |
| Revenue (latest FY) | $510.17M | - |
| Net income (latest FY) | $146.93M | - |
| Net margin | 28.8% | - |
| P/E (trailing FY) | 13.0 | - |
| SEC filings | 988 | 548 |
BioNTech SE is 12.0x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($22.90 B vs $1.90 B).
Full pages: ADMA BIOLOGICS, INC. and BioNTech SE, or browse the full rankings.